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Abstract
Objective. Salivary gland secretion is dependent on cholinergic stimulation via autonomic nerves and
calcium signalling in acinar cells. Secretory dysfunction associated with SS may be partly caused by the
damaging effects of increased glandular concentrations of nitric oxide (NO) derived from up-regulation of
inducible NO synthase (iNOS) that accompanies glandular inflammation. The present study examines
the effects of increased iNOS expression on salivary gland secretory function.
Methods. The inflammogen lipopolysaccharide (LPS) was introduced intraductally into rat submandibular
glands, and glandular responsiveness to cholinergic stimulation was determined.
Results. LPS provoked a rapid, long-lasting inflammation, increasing gland weight (by almost 20%) and
inflammatory cell infiltration at 3 and 24h. Immunoblotting of glandular homogenates indicated that iNOS
expression was increased  4-fold, and immunohistochemistry of frozen tissue sections showed increased
iNOS expression in acinar cells. Salivary secretion from inflamed glands was significantly increased in
response to low doses of methacholine and accompanied by increased acinar cell calcium signalling
in vitro. Prior administration of the iNOS inhibitors, aminoguanidine or L-NIL [L-N6-(1-iminoethyl)-lysine
dihydrochloride] abolished increased secretion and acinar cell calcium signalling.
Conclusions. Up-regulation of glandular iNOS expression can increase cholinergically evoked salivary
secretion and appears to offset any secretory hypofunction linked with glandular inflammation. It seems
unlikely that increased glandular levels of NO are responsible for the secretory hypofunction that
accompanies SS.
Key words: Sjo ¨gren’s syndrome, Salivary gland, Secretory hypofunction, Nitric oxide, Inducible nitric oxide
synthase, Cholinergic, Rat submandibular, Lipopolysaccharide.
Introduction
Fluid secretion from many exocrine glands including
salivary, lacrimal and submucosal glands is dependent
on signalling from parasympathetic autonomic nerves
evoking increases in acinar cell calcium concentration
mediated by muscarinic receptors and, to a lesser
extent, other non-cholinergic receptors [1]. SS is a chronic
autoimmune inflammatory disease characterized by loss
of exocrine gland secretory function causing dryness of
mucosal surfaces and accompanying glandular tissue
destruction [2]. Recent research by different investigators
indicates that exocrine gland hypofunction is not neces-
sarily correlated with the degree of secretory tissue
destruction and that other non-destructive mechanisms,
for example anti-M3 muscarinic receptor antibodies or
reduced acetylcholine release from parasympathetic
nerves, may play a significant role (see recent review by
Dawson et al. [3]). A potentially significant factor in altering
salivary secretion in SS is nitric oxide (NO), since nitrite is
present at increased concentrations in saliva from SS
patients and inducible NO synthase (iNOS) expression is
increased in acinar and other cells in labial salivary glands
of patients [4]. Prolonged exposure of mice to IL-12 and
-18 induced widespread salivary and lacrimal cell
apoptosis, which was absent in iNOS knockout mice [5].
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ENO generated from the constitutive NOS enzymes, neural
NOS (nNOS) and endothelial NOS (eNOS), is also an
important signalling molecule in mediating salivary secre-
tion, since it modifies acinar cell calcium signalling in
response to autonomic stimulation [6, 7].
Given the potential importance of NO in mediating the
exocrine hypofunction associated with SS syndromes, we
have studied a model in which iNOS is up-regulated in the
submandibular (SM) gland. Bacterial lipopolysaccharide
(LPS) or endotoxin is frequently used as an inflammogen
in studies of cell and tissue function during inflammation
[8]. LPS requires the active response of host cells resulting
in the production of pro-inflammatory cytokines such as
IL-1b and TNF-a and leading to increased expression of
iNOS [9]. Previous studies of the effects of LPS on salivary
secretion have usually delivered the inflammogen sys-
temically resulting in endotoxaemia [10, 11]. In the present
model, LPS was directly instilled into the rat SM gland
by retrograde injection into the main excretory duct thus
reducing the systemic effects.
Materials and methods
Intraductal injection ofLPS
All procedures on rats were performed with approval from
the local Animal Ethics and Welfare Committee and under
a Home Office project licence according to Home Office
regulations (guidance on the operation on animals was
from the Scientific Procedures Act 1986).
Young adult male Wistar strain rats (Harlan Labs,
Loughborough, UK), weighing 222–345g, were housed
under standard conditions (12h light/dark cycle at
22–25 C) with a chow pellet diet and water ad libitum.
The animals were anaesthetized with ketamine
(75mg/kg) and xylazine (15mg/kg) i.p. Under anaesthesia,
50ml of LPS (Escherichia coli serotype O111:B4,
0.5mg/ml, Sigma-Aldrich Company Ltd, Gillingham,
Dorset, UK) in saline were injected in the right SM gland
duct from an intra-oral approach, with the help of a
dissecting microscope. In three rats, the right SM gland
received the same volume of saline only. The contralat-
eral, left gland was left untreated. After 3 or 24h, saliva
collection was performed, as described below.
In three rats, dexamethasone intramuscular (3mg/kg)
was administered 30min before the intraductal injection
of LPS, in order to reach the peak plasma level by the time
LPS was given. Then, 1h and 30min after the LPS
injection (i.e. 2h after the previous dexamethasone
dose), a booster of dexamethasone intramuscular
(3mg/kg) was given, since this drug has an elimination
half life of 2.3h in the rat [12].
Stimulation of salivary secretion
Salivary secretion was stimulated at 3 or 24h after the
ductal infusion of LPS. Rats were anaesthetized with
pentobarbitone (50mg/kg) intraperitoneal A cannula was
introduced into the femoral vein and chloralose (80mg/kg)
(Sigma-Aldrich Company Ltd, Gillingham, Dorset, UK) was
delivered intravenous to maintain long-term anaesthesia
and additional pentobarbitone was given if necessary.
The trachea was cannulated providing a clear airway
during infusion of methacholine, and body temperature
was maintained at 38 C. Saline was given i.p. to maintain
fluid levels.
For collection of saliva, the SM ducts were exposed,
from an extra-oral, ventral approach, and cannulated
proximal to the gland. Salivation was stimulated with
methacholine (acetyl-b-methylcholine chloride; Sigma-
Aldrich Company Ltd, Gillingham, Dorset, UK) diluted in
saline to 48 or 144mg/ml (0.25 or 0.74mM). A calibrated
syringe pump was adjusted to deliver 4mg/min/kg
(low dose) or 12mg/min/kg (high dose) as previously
described [13]. Saliva was collected from both ducts.
In some experiments, the specific iNOS inhibitors L-NIL
[L-N6-(1-iminoethyl)-lysine dihydrochloride; Acros
Organics, Geel, Belgium] or aminoguanidine (AG; amino-
guanidine hydrochloride, 98þ%, Sigma) were given i.v.
at doses of 10 or 100mg/kg [14], respectively, to ensure
complete inhibition of iNOS enzyme. After 30min, to allow
the iNOS inhibitors to reach maximum plasma concen-
tration, doses of methacholine were given and saliva
was collected as above.
Immediately following the final salivary collection
period, each SM gland was removed, separated from
the sublingual gland, and weighed. The animals were
killed with an overdose of pentobarbitone.
After removal, each SM gland was divided into five
pieces. For biochemical analyses, tissue pieces were
immediately frozen in liquid nitrogen. For morphological–
immunohistochemical studies, tissues were placed in
optimal cutting temperature embedding medium
(Thermo Fischer Scientific, Runcorn, Cheshire, UK), then
frozen in a vessel of isopentane cooled in liquid nitrogen.
For conventional histochemistry, tissues were immersion-
fixed in formol sucrose (4% w/v formaldehyde, 7.5% w/v
sucrose and 0.08M cacodylate buffer, pH 7.2).
Salivary cell calcium imaging invitro
Twenty-four hours following an infusion of LPS, SM glands
were removed from anaesthetized rats, minced, and
digested by collagenase (5mg/20ml buffer) as previously
described [15]. After  2h, cells from collagenase-
digested glands were loaded with the calcium-sensitive
dye Fluo-4 AM (4mM; Invitrogen, Paisley, UK) and
stimulated with increasing doses of methacholine (10
 8
and 10
 7M), then ionomycin (13mM) and finally
manganese chloride (2mM) to calibrate levels of dye
within each cell [16]. Some cell preparations were addi-
tionally incubated with the iNOS inhibitor AG (100mg/ml)
for a period of 30min before addition of Fluo-4 AM. These
cells were subsequently stimulated in the absence and
then in the presence of AG, which was included in the
cell media. The experiments were completed by 3–4h
following removal of tissue from rats. Fluorescence
levels were assessed in cells with an acinar mor-
phology using a confocal microscope (TCS SP2;
Leica Microsystems, Milton Keynes, UK) and relative
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maximum and minimum values.
Analysis of proteincomposition ofglandular extracts
SM gland pieces were homogenized in 10 vol of
0.1M phosphate buffer, pH 6, containing 2mM
ethylenediaminetetraacetic acid (EDTA), 1.6mM Triton
X-100 and a protease inhibitor cocktail (CN Biosciences
Ltd, Beeston, UK) using a blade homogenizer (Ultra-
Turrax; Janke & Kunkel, Lewes, UK) at a speed of
20000r.p.m. for three cycles of 10s on ice. Aliquots of
the homogenate were stored at  20 C, whereas the
remaining homogenate was then centrifuged for 5min
at 11000g.a t4  C and the supernatant (tissue extract)
was removed and stored at  20 C.
SDS–PAGE andwestern blotting
Proteins in 10ml of 10% tissue extracts of SM glands
were separated by SDS–PAGE under reducing conditions
in 4–12% Bis–Tris gels (Invitrogen) according to the
manufacturer’s instructions. After electrophoresis,
proteins separated by SDS–PAGE were transferred onto
nitrocellulose membranes (PROTRAN; Schleicher &
Schuell UK Ltd, London, UK) that were then stained with
FITC (Sigma-Aldrich Company Ltd, Gillingham, Dorset,
UK) to confirm the extent of protein transfer.
Nitrocellulose membranes were treated with Protoblock
(National Diagnostics, Hessle, East Riding, UK) for
45min in order to block non-specific protein binding
sites, followed by incubation with rabbit anti-iNOS poly-
clonal antibody (Santa Cruz Biotechnology, Heidelberg,
Germany) at a dilution of 1/1000 in tris-buffered saline
(TBS) containing 0.1% Tween 20 (TTBS) for 45min.
After washing with TTBS, blots were incubated with a
goat anti-rabbit HRP-conjugated secondary antibody
(1/2000, Dako, Ely, UK) for 45min and positive bands
detected using chemiluminescence substrate consisting
of a solution of 250mM luminol, 90mM coumaric acid
and 30% hydrogen peroxide in TBS.
Assay ofglandular MPOactivity
Following centrifugation, the tissue pellets from glandular
homogenates, prepared as above, were resuspended in
phosphate buffer containing 13.7mM hexadecyltrimethy-
lammonium bromide (Sigma) and 10mM EDTA. The
samples were diluted and loaded onto a 96-well
microplate and placed in a water bath at 37 C.
Hydrogen peroxide, phosphate buffer and TMB
(3,30,5,50-tetramethyl-benzidine) were added sequentially.
The substrate reaction was stopped after 4min by 2M
sulphuric acid. The absorbance of the sample reaction
was read at 450nm (Microplate reader; Labsystems
iEMS Reader MF). Different dilutions of human MPO
enzyme of known concentration were used to obtain the
standard curve (Sigma). MPO activity was expressed as
milliunits per gram tissue. Dapsone (diaminodiphenylsul-
fone; Sigma), a selective inhibitor of peroxidases,
other than MPO, was used to confirm the specificity of
the assay [17].
Morphological analysis of salivary glands
Formol sucrose-fixed tissue was processed to paraffin
wax embedding and 5-mm sections were cut, mounted
on slides and stained with Ehrlich haematoxylin and 1%
eosin (H&E).
Frozen tissue sections of 6mm were fixed with 100%
methanol for 10min and then allowed to dry at room
temperature for 30min. Endogenous peroxidase was
blocked with 0.3% H2O2 for 5min before rehydration in
phosphate-buffered saline (PBS) and H2O. Slides were
then treated with goat serum (Dako) followed by overnight
incubation at 4 C with a 1/50 dilution of primary anti-iNOS
rabbit polyclonal antibody IgG (Universal Biologicals Ltd,
Papworth St Agnes, UK) diluted in PBS. The slides were
then washed twice in PBS and incubated at room
temperature for 1h with the secondary antibody (1/200),
HRP-conjugated goat anti-rabbit IgG (Dako). Sections
were washed and then developed with diaminobenzidine
substrate (Merck Serono Ltd, Feltham, UK). Sections were
then stained with Mayer’s haematoxylin, dehydrated in a
gradient of alcohol, cleared in xylene and covered and
viewed under a light microscope. Liver sections were
included as positive controls following the method
above. Secondary antibody controls were performed
using liver and SM gland sections. Separate sections
were also incubated with PBS alone.
Assay oftotal protein in saliva
Total salivary protein was assayed spectrophotometrically
by diluting saliva samples in the ratio 1/100 with double
distilled water and reading absorbance at 215nm using
a spectrophotometer (Ultrospec 4050; Biochrom Ltd,
Cambridge, UK). Double-distilled water was used as a
blank and bovine serum albumin (Sigma) was used to
construct a standard curve.
Statistical analysis
Data were analysed using paired Student’s t-test when
comparing contralateral glands from the same group
and unpaired Student’s t-test for comparisons between
glands in the dexamethasone-treated and -untreated
series. For comparisons of intracellular calcium levels in
cells in vitro, an unpaired t-test was used with the Holm–
Bonferonni correction for multiple comparisons. Results
are expressed as mean (S.E.M.) and P<0.05 was
considered as statistically significant.
Results
SMgland inflammation
In a preliminary time-course study, salivary gland weight
was found to be increased at 1.5, 3, 6 and 24h but
returned to normal at 72h following introduction of LPS.
Larger numbers of rats were studied at 3h (n¼10) and
24h (n¼38) following LPS, and mean gland weights were
significantly increased at both time points by 17 and 19%,
respectively (Fig. 1), whereas the mean weight of the
sublingual gland, present in the same connective tissue
capsule but not injected with LPS, was unaffected
50 www.rheumatology.oxfordjournals.org
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(0.001) g and treated glands 0.04 (0.004) g].
Gland enlargement was accompanied by inflammatory
cell infiltration, although the extent of the latter differed at
the two time points being an extensive infiltration of par-
enchymal tissue at 24h but more restricted to peri-ductal
connective tissue at 3h (Fig. 2). Histological examination
of tissue at 72 and 96h following LPS administration
showed that inflammatory cells persisted in periductal
connective tissue (data not shown).
In experiments where rats received dexamethasone
intramuscular 30min before intraductal infusion of LPS,
there was no increase in SM gland weight compared
with the contralateral control side at 3h [0.2 (0.01) g LPS
treated; 0.2 (0.016) g control gland, n¼4], nor was there
any evidence of inflammatory cell infiltration. MPO activity
was used as a quantitative index of gland inflammatory
cell infiltration and was elevated in LPS injected glands
after 24h (Fig. 1b). Retrograde ductal injection of the
same volume of saline (the vehicle for LPS) did not
result in gland enlargement compared with the contralat-
eral gland, nor was there inflammatory cell infiltration
or increased MPO activity (data not shown).
Expression of iNOS inSM glands
Western blots of SM gland homogenates probed with an
antibody to iNOS showed an immunoreactive band of
similar mobility ( 130kDa) to a standard preparation of
iNOS from LPS-activated mouse macrophages (Fig. 3).
Expression of iNOS was already increased at 3h after
infusion of LPS, compared with the contralateral control
gland that showed no or little expression of iNOS (data not
shown). Twenty-four hours following LPS infusion, SM
gland extracts showed an intense immunoreactive band
of iNOS (Fig. 3a). When the primary antibody was absent,
no immunostaining of gland extracts or standard iNOS
was seen (data not shown). On some occasions, a faint
immunoreactive iNOS band was seen in contralateral
control homogenates 24h following LPS infusion.
Expression of iNOS in western blots was quantified by
digital scanning and measurement of band intensity;
24h following LPS, iNOS expression was increased by
 6-fold (Fig. 3b). Samples (n¼2) of LPS-infused and con-
trol glands, which received dexamethasone systemically,
were also assessed for the expression of iNOS. Under
these conditions, there was no immunoreactivity for
a band of the molecular weight of iNOS (data not
shown). Likewise, there was no expression of iNOS in
saline-treated and -untreated control glands (Fig. 3b).
In order to localize the expression of iNOS in the SM
gland, immunohistochemistry was performed on frozen
tissue sections. Strong iNOS immunoreactivity was
detected in acini 24h following LPS treatment (Fig. 4b).
Incubation without primary antibody showed no binding of
the secondary antibody to the tissue section and there
was little or no expression in contralateral control glands
(Fig. 4a).
SMgland secretion
In order to evaluate secretory function in inflamed SM
glands, the muscarinic cholinergic agonist methacholine
was infused intravenously at two different doses. At the
lower dose of methacholine, salivary flow from inflamed
glands was 58% greater at 3h following an infusion of LPS
(Fig. 5a). Salivary flow from infused glands at 24h follow-
ing LPS gland was increased by 128% compared with
contralateral control glands (Fig. 5b). The higher dose of
methacholine did not evoke increased mean salivary
flow from inflamed glands compared with control glands
at 3 or 24h following LPS (Fig. 5a).
Total protein secretion into saliva showed a similar
trend to fluid secretion. The lower dose of methacholine
evoked greater total protein secretion from inflamed
glands at 3h compared with control glands [50.5 (6.7) vs
24.2 (4.2)mg/min/g gland wet weight; n¼4; P¼0.009].
At 24h, protein secretion from inflamed glands remained
elevated [56.4 (17.6) vs 25.7 (6.3)mg/min/g gland wet
weight; n¼8; P¼0.040]. A higher dose of methacholine
FIG.1Submandibular gland inflammation 3 or 24h
following an intraductal infusion of lipopolysaccharide
(LPS). (a) Mean submandibular (SM) gland weight was
increased by 17% at 3h (n¼10) following LPS. At 24h
(n¼38) following LPS the increase in SM gland weight
was 19%. (b) Myeloperoxidase (MPO) activity per gram
wet weight of submandibular glands at 24h after LPS
treatment (n¼6) was increased compared to contralateral
control glands but at 3h following LPS treatment (n¼7)
the increase did not reach statistical significance. Results
are expressed as means (S.E.M.). Differences between
values in paired glands were compared using a Student’s
paired t-test and P<0.05 was considered statistically
significant. *P¼0.006, ***P<0.0001 and **P¼0.002
compared to contralateral control glands.
(a)
0.000
0.050
0.100
0.150
0.200
0.250
0.300
0.350
24h LPS 3h LPS
G
l
a
n
d
 
W
e
i
g
h
t
 
(
g
)
 
(b)
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
Control 3h LPS Control 24h LPS
24h LPS 3h LPS
Control 3h LPS Control 24h LPS
M
y
e
l
o
p
e
r
o
x
i
d
a
s
e
 
(
U
.
g
–
1
)
*** 
*
**
www.rheumatology.oxfordjournals.org 51
Salivary gland secretionevoked no significant difference in protein secretion from
inflamed compared with control glands.
In a further series of experiments, the effect of iNOS
inhibitors (AG or L-NIL) on salivary secretion was exam-
ined. Following intravenous infusion of either inhibitor,
salivary flow rate evoked from inflamed glands by a low
dose of methacholine was only 10% of the flow rate
before infusion of inhibitor. Secretion from contralateral
control glands was unaffected by the iNOS inhibitor, and
consequently the salivary flow rate from inflamed glands
was 84% less than the flow from the control glands.
In response to high-dose methacholine, secretion from
inflamed glands was  38% of the controls following
inhibition of iNOS (Fig. 5b).
Calcium signalling inSM cells
In vitro experiments were conducted using clusters of
collagenase-digested acini from SM glands, which were
then loaded with the calcium-sensitive dye Fluo-4. When
stimulated with two doses of methacholine, acinar
clusters viewed under the confocal microscope showed
typical biphasic responses consisting of an initial peak
followed by a plateau of intracellular calcium concentra-
tion returning to baseline on cessation of the stimulus.
Salivary acinar cells taken from inflamed glands showed
higher peaks and plateaux of intracellular calcium concen-
tration in response to methacholine (Fig. 6). In order to
express the data quantitatively, maximal attainable
calcium-induced fluorescence was determined in
response to ionomycin, a calcium ionophore. When the
plateaux values for stimulated intracellular calcium
obtained from several experiments were combined and
expressed as mean values, the differences showed
statistical significance (Fig. 6c). Intracellular calcium
levels in SM acini were unaffected by an acute application
of LPS to acinar clusters in vitro (data not shown).
In a further set of in vitro experiments, intracellular cal-
cium was determined in acinar cells from glands following
in vitro incubation with the iNOS inhibitor AG. Whereas
methacholine-evoked calcium levels in acinar cells from
control glands remained unaffected by prior incubation
with AG, fluorescence levels in cells from inflamed
glands were no longer statistically greater than AG-treated
control cells (Fig. 6d).
Discussion
The present study is relevant to our understanding of the
mechanism of secretory hypofunction observed in SS,
since we have examined secretory function in an animal
FIG.2 Submandibular gland morphology following infusion of LPS. (a)–(d) Sections of submandibular (SM) gland stained
with Ehrlich Haematoxylin and 1% Eosin. (a)&( b) Sections of contralateral control (a) and treated glands (b) 3h following
infusion of LPS. (c)&( d) Sections of control (c) and treated (d) glands 24h following infusion of LPS. Arrows indicate
accumulations of inflammatory cells focussed around blood vessels in connective tissue at 3h but distributed more
widely in parenchyma at 24h. All glands were examined morphologically and showed similar patterns of inflammatory cell
infiltration. Magnification  125, scale bar¼20mm.
(a) (b)
(c) (d)
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expression accompanying salivary gland inflammation.
Increased iNOS expression and salivary levels of
NO-derived nitrite are features of SS [4]. Up-regulation
of iNOS expression can have detrimental effects on cell
and tissue function, principally because NO reacts with
superoxide to produce peroxynitrite, an oxidation product
that at high concentrations can alter the function of
proteins, nucleic acids and lipids [18]. Thus, it can be
hypothesized that up-regulation of iNOS expression may
lead to secretory hypofunction in SS [4, 3], possibly by
interfering with important protein signalling molecules [18].
LPS infused intraductally into the rat SM gland proved
to be a very effective inflammogen, since there was a
rapid increase in gland weight at 3h. Similar results
were obtained previously in rat parotid and SM glands
at 3 and 6h following intraductal administration of
LPS [19]. It has been shown in mouse SM glands that
LPS-induced inflammation is dependent upon expression
of TLR-4 [20]. The downstream intracellular signalling
pathway following LPS binding to TLR-4 involves activa-
tion of the nuclear factor-kB pathway and up-regulation
of the expression of inflammatory cytokines, iNOS and
cyclooxygenase-2 (COX-2) [21]. We found that there
was a sustained up-regulation of iNOS expression in
inflamed glands between 3 and 24h following LPS
infusion as indicated by immunocytochemistry and
western blots. However, despite the chronic exposure of
acinar cells to increased NO derived from up-regulation of
iNOS expression, salivary secretion evoked by a low dose
of methacholine remained elevated at 24h as it was at 3h
following LPS infusion. No increased responsiveness was
seen in LPS-treated glands treated with the high-dose
methacholine, most likely because the high dose
produces a supramaximal secretory response that is not
to be enhanced by increased levels of NO. Inducible NOS
expression was not examined at longer time points
following LPS. If expression remained elevated, it may
be that there were further changes in salivary secretory
responses. An isolated experiment at 96h following LPS
FIG.3Expression of inducible nitric oxide synthase
(iNOS) 24h following LPS treatment of submandibular
glands. (a) The figure shows extracts from four sets of
paired LPS-treated (L) and contralateral control (C)
submandibular glands. An immunoreactive band of the
predicted molecular weight for iNOS, (130kDa) was
observed in extracts of LPS treated glands but
undetectable in contralateral control glands. The
immunoreactive band in gland extracts was compared
with standard iNOS (S) from an extract of stimulated
mouse macrophages. (b) Band intensities in digital images
of two iNOS Western blots were determined and are
presented as arbitrary units. iNOS expression in
extracts of five LPS treated glands was increased by
approximately 6-fold compared to control glands. Saline
treated gland extracts (n¼5) show no increase in iNOS
expression. *P¼0.002 vs control glands and saline-
treated glands. Results are expressed as means (S.E.M.).
Differences between values in paired glands were
compared using a Student’s paired t-test and P<0.05
was considered statistically significant.
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FIG.4 Immunohistochemical distribution of inducible nitric
oxide synthase (iNOS) 24h following an infusion of LPS.
Control submandibular glands (a) showed little expression
of iNOS whilst 24h following an infusion of LPS (b) iNOS
was widely distributed in acini (arrow) and inflammatory
cells (arrow-heads). Such increased iNOS expression was
observed in 3 LPS treated glands that were examined.
Magnification x125.
(a)
(b)
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Salivary gland secretionFIG.5Submandibular gland secretion of saliva following
intraductal infusion of LPS. (a)A t3 h( n¼7) and (b)a t
24h (n¼12) following a single intraductal infusion of LPS,
secretion of submandiblar saliva was increased in
response to a low dose (4mgmin
 1kg
 1, i.v.) of
methacholine (L Meth). Saliva secretion was similar
between LPS-treated and contralateral control glands
in response to a high dose (12mgmin
 1kg
 1, i.v.) of
methacholine (H Meth). (c)A t2 4h( n¼4) following
LPS treatment saliva secretion was again increased in
response to a low dose (4mgmin
 1kg
 1, i.v.) of
methacholine (L Meth). Following the specific iNOS
inhibitor aminoguanidine (100mgml
 1, i.v.) there was a
greatly reduced secretion response to a low (L Meth)
and high doses (H Meth) of methacholine. Results are
expressed as means (S.E.M.) per gram wet weight of
gland. Differences between values in paired glands were
compared using a Student’s paired t-test and P<0.05
was considered statistically significant. ***P¼0.003,
****P¼0.001, **P¼0.01 and *P¼0.03 vs control gland
at the same dose. *****P¼0.0007 vs LPS treated
gland before iNOS inhibitor.
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FIG.6Intracellular calcium signalling in acinar cells from
LPS-treated glands following cholinergic stimulation.
Typical traces showing intracellular calcium levels (as
relative fluorescence) in acinar cells loaded with the
calcium sensitive dye Fluo 4-AM and monitored by
confocal microscope. Twenty four hours following LPS
treatment acinar cells prepared from (a) LPS-treated and
(b) -untreated contralateral control glands were stimulated
with two doses of 10 and 100nM methacholine followed
by ionomycin (Iono) in order to gain the maximum
fluorescence signal. (c) Quantification (mean (S.E.M.) of
fluorescence intensities in acinar cells prepared from three
pairs of submandibular glands. Resting calcium level in
these cells was 0.12 0.02. All values are a fraction of
maximum fluorescence generated during ionophore
incubation (set to 1). Acinar cells from LPS treated glands
showed higher intracellular calcium levels in response to
methacholine, particularly the lower dose (10nM). When
cells from LPS treated and control glands were pre-
incubated with the iNOS inhibitor aminoguanidine (AG) for
30min prior to stimulation intracellular calcium levels in
response to methacholine were similar in cells from
LPS treated glands compared to control glands. Prior
incubation with AG reduced the calcium response in cells
from LPS treated glands. ***Corrected P-value¼0.001
and *corrected P-value¼0.039 compared to same
methacholine dose in control cells from an untreated
gland. **Corrected P-value¼0.004 compared to same
methacholine dose in cells from LPS treated glands
without prior incubation with AG.
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Patricia N. Correia et al.showed similar secretory responses for both treated and
contralateral control glands (data not shown).
Hypersecretion from inflamed glands was abolished
when rats were given the NOS inhibitors L-NLL or AG.
Since both of these inhibitors show a high selectivity for
iNOS over nNOS or eNOS [14], the results indicate
that NO derived from iNOS plays a key role in mediating
glandular hypersecretion. The mechanism leading to
hypersecretion may involve acinar cell calcium signalling,
since methacholine-evoked intracellular calcium concen-
trations were greater in cells from inflamed glands but
returned to normal values when cells were incubated
with iNOS inhibitor. NO can modulate salivary secretion
through a pathway involving guanylate cyclase/cyclic
guanidine monophosphate and adenosine diphosphate
ribosyl cyclase/cyclic adenosine diphosphate ribose [7].
The latter mediator activates ryanodine-sensitive calcium
channels leading to release of calcium from rough
endoplasmic reticulum [6, 7].
The details of how NO influences salivary secretion vary
depending on species, gland and study. However, there is
a body of evidence indicating that NO derived from acinar
cell nNOS, nNOS in autonomic nerves or endothelial cell
eNOS can influence salivary secretion [7, 10, 15, 22–25],
since NO is a freely permeable small molecule that rapidly
signals over short distances [17]. NO alone produces only
modest increases in intracellular calcium as indicated
by in vitro studies using NO donors such as SNAP
(S-nitroso-N-acetyl-penicillamine) [7]. Likewise, we found
that basal levels of intracellular calcium were not elevated
in cells from LPS-treated glands although iNOS
expression was increased.
Inhibition of iNOS by AG or L-NLL revealed a secretory
hypofunction in LPS-treated glands in response to choli-
nergic stimulation at both doses of methacholine. Such
hypofunction may be due to the action of other inflamma-
tory mediators, possibly through inducible COX-2 and
prostaglandin signalling as previously suggested [10].
However, the in vitro studies suggest that hypofunction
following inhibition of iNOS activity is not due to reduced
cholinergically stimulated levels of intracellular calcium.
In conclusion, the results obtained using the present
model of LPS-induced inflammation suggest that raised
NO derived from increased iNOS expression enhances
intracellular calcium signalling and increases fluid
secretion.
Rheumatology key messages
. Up-regulation of iNOS leads to increased choliner-
gically evoked salivary secretion.
. Increased NO may offset glandular hypofunction
seen in SS.
Acknowledgement
Funding: Project grant funding by the Wellcome Trust.
Funding to pay the Open Access publication charges for
this article was provided by the Wellcome Trust.
Disclosure statement: The authors have declared no
conflicts of interest.
References
1 Proctor GB, Carpenter GH. Regulation of salivary gland
function by autonomic nerves. Auton Neurosci 2007;133:
3–18.
2 Ramos-Casals M, Font J. Primary Sjo ¨gren’s syndrome:
current and emergent aetiopathogenic concepts.
Rheumatology 2005;44:1354–67.
3 Dawson LJ, Fox PC, Smith PM. Sjo ¨grens syndrome - the
non-apoptotic model of glandular hypofunction.
Rheumatology 2006;45:792–8.
4 Konttinen YT, Platts LAM, Tuominen S, Eklund KK,
Santavirta N, Tornwall J et al. Role of nitric oxide in
Sjo ¨gren’s syndrome. Arthritis Rheum 1997;40:875–83.
5 Kimura-Shimmyo A, Kashiwamura SI, Ueda H, Ikeda T,
Kanno S, Akira S et al. Cytokine-induced injury of the
lacrimal and salivary glands. J Immunother 2002;25:
S42–51.
6 Harmer AR, Gallacher DV, Smith PM. Role of Ins(1,4,5)P-3,
cADP-ribose and nicotinic acid-adenine dinucleotide
phosphate in Ca
2þ signalling in mouse submandibular
acinar cells. Biochem J 2001;353:555–60.
7 Looms DK, Tritsaris K, Nauntofte B, Dissing S. Nitric oxide
and cGMP activate Ca
2þ-release processes in rat parotid
acinar cells. Biochem J 2001;355:87–95.
8 Bosshart H, Heinzelmann M. Targeting bacterial endotoxin
- two sides of a coin. Signal Transduct Pathways 2007;
1096:1–17.
9 Dinarello CA. Proinflammatory and anti-inflammatory
cytokines as mediators in the pathogenesis of septic
shock. Chest 1997;112:321S–9S.
10 Lomniczi A, Mohn C, Faletti A, Franchi A, Mccann SM,
Rettori V et al. Inhibition of salivary secretion by
lipopolysaccharide: possible role of prostaglandins. Am J
Physiol Endocrinol Metab 2001;281:E405–11.
11 Kawabata A, Kuroda R, Morimoto N, Kawao N, Masuko T,
Kakehi K et al. Lipopolysaccharide-induced subsensitivity
of protease-activated receptor-2 in the mouse salivary
glands in vivo. Naunyn Schmiedebergs Arch Pharmacol
2001;364:281–4.
12 Suitthimeathegorn O, Turton JA, Mizuuchi H, Florence AT.
Intramuscular absorption and biodistribution of
dexamethasone from non-aqueous emulsions in the rat.
Int J Pharm 2007;331:204–10.
13 Osailan SM, Proctor GB, Carpenter GH, Paterson KL,
McGurk M. Recovery of rat submandibular salivary gland
function following removal of obstruction: a sialometrical
and sialochemical study. Int J Exp Pathol 2006;87:411–23.
14 Proskuryakov SY, Konoplyannikov AG, Skvortsov VG,
Mandrugin AA, Fedoseev VM. Structure and activity of NO
synthase inhibitors specific to the L-arginine binding site.
Biochemistry 2005;70:8–23.
15 Xu X, Diaz J, Zhao H, Muallem S. Characterization,
localization and axial distribution of Ca
2þ signalling
receptors in the rat submandibular salivary gland ducts.
J Physiol 1996;491:647–62.
16 Carpenter GH, Osailan SM, Correia P, Paterson KP,
Proctor GB. Rat salivary gland ligation causes reversible
secretory hypofunction. Acta Physiol 2007;189:241–9.
www.rheumatology.oxfordjournals.org 55
Salivary gland secretion17 Thomas EL, Jefferson MM, Joyner RE, Cook GS, King CC.
Leukocyte Myeloperoxidase and Salivary
Lactoperoxidase - Identification and Quantitation in
Human Mixed Saliva. J Dent Res 1994;73:544–55.
18 Pacher P, Beckman JS, Liaudet L. Nitric oxide and
peroxynitrite in health and disease. Physiol Rev 2007;87:
315–424.
19 Darnell M, Aras HC, Magnusson B, Ekstrom J.
Lipopolysaccharide induced-in vivo increases in
beta-defensins of the rat parotid gland. Arch Oral Biol
2006;51:769–74.
20 Yao CJ, Li XF, Murdiastuti K, Kosugi-Tanaka C,
Akamatsu T, Kanamori N et al. Lipopolysaccharide-
induced elevation and secretion of interleukin-1 beta in the
submandibular gland of male mice. Immunology 2005;
116:213–22.
21 Bonizzi G, Karin M. The two NF-kappa B activation
pathways and their role in innate and adaptive immunity.
Trends Immunol 2004;25:280–8.
22 Takai N, Uchihashi K, Higuchi K, Yoshida Y,
Yamaguchi M. Localization of neuronal-constitutive nitric
oxide synthase and secretory regulation by nitric oxide in
the rat submandibular and sublingual glands. Arch Oral
Biol 1999;44:745–50.
23 Sayardoust S, Ekstrom J. Nitric oxide-dependent in vitro
secretion of amylase from innervated or chronically
denervated parotid glands of the rat in response to
isoprenaline and vasoactive intestinal peptide. Exp Physiol
2003;88:381–7.
24 Sakai T, Michikawa H, Furuyama S, Sugiya H.
Methacholine-induced cGMP production is regulated by
nitric oxide generation in rabbit submandibular gland cells.
Comp Biochem Physiol B Biochem Mol Biol 2002;132:
801–9.
25 Sugiya H, Mitsui Y, Michikawa H, Fujita-Yoshigaki J,
Hara-Yokoyama M, Hashimoto S et al.C a
2þ-regulated
nitric oxide generation in rabbit parotid acinar cells. Cell
Calcium 2001;30:107–16.
56 www.rheumatology.oxfordjournals.org
Patricia N. Correia et al.